SE8304009D0 - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
SE8304009D0
SE8304009D0 SE8304009A SE8304009A SE8304009D0 SE 8304009 D0 SE8304009 D0 SE 8304009D0 SE 8304009 A SE8304009 A SE 8304009A SE 8304009 A SE8304009 A SE 8304009A SE 8304009 D0 SE8304009 D0 SE 8304009D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
vinca
leuraformine
leurosidine
vindesine
Prior art date
Application number
SE8304009A
Other languages
Swedish (sv)
Other versions
SE463804B (en
SE8304009L (en
Inventor
R L Robison
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8304009D0 publication Critical patent/SE8304009D0/en
Publication of SE8304009L publication Critical patent/SE8304009L/en
Publication of SE463804B publication Critical patent/SE463804B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention provides stable, sterile, ready-to-use formulations of oncolytic vinca dimers comprising an aqueous solution of the vinca dimer (e.g. vincristine, vinblastine, vindesine, 4 min -deoxy-1-formyl-leurosidine or leuraformine) as a pharmaceutically acceptable water-soluble salt, an acetate buffer maintaining the pH between 3.0 and 5.0, a polyol (e.g. lactose, mannitol, sorbitol), and a preservative which is preferably methyl paraben and/or propyl paraben.
SE8304009A 1982-07-19 1983-07-15 AN APPLICABLE PHARMACEUTICAL COMPOSITION OF WINE ADDITIONAL SALTS SE463804B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39965482A 1982-07-19 1982-07-19
US47607783A 1983-03-17 1983-03-17

Publications (3)

Publication Number Publication Date
SE8304009D0 true SE8304009D0 (en) 1983-07-15
SE8304009L SE8304009L (en) 1984-01-20
SE463804B SE463804B (en) 1991-01-28

Family

ID=27016716

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304009A SE463804B (en) 1982-07-19 1983-07-15 AN APPLICABLE PHARMACEUTICAL COMPOSITION OF WINE ADDITIONAL SALTS

Country Status (16)

Country Link
AU (1) AU553514B2 (en)
BE (1) BE897280A (en)
CH (1) CH654744A5 (en)
DE (1) DE3324964A1 (en)
FR (1) FR2531860B1 (en)
GB (1) GB2125292B (en)
HK (1) HK43087A (en)
HU (1) HU191538B (en)
IE (1) IE55388B1 (en)
IL (1) IL69203A (en)
IT (1) IT1170152B (en)
LU (1) LU84910A1 (en)
NL (1) NL184146C (en)
NZ (1) NZ204868A (en)
PH (1) PH19098A (en)
SE (1) SE463804B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (en) * 1986-04-25 1989-06-02 Pf Medicament STABLE AQUEOUS SOLUTION OF VINCRISTINE SULFATE
FR2623089B1 (en) * 1987-11-13 1990-04-27 Pf Medicament PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION OF NAVELBINE
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
FR2910812B1 (en) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa LYOPHILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS OF HEMI-SYNTHETIC STABLE VINCA ALKALOID DERIVATIVES AT AMBIENT TEMPERATURE
WO2017021981A1 (en) 2015-08-01 2017-02-09 Sun Pharmaceutical Industries Ltd. Dosage form of vinca alkaloid drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3749784A (en) * 1972-05-03 1973-07-31 Lilly Co Eli Psoriasis treatment
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
US4208414A (en) * 1978-06-05 1980-06-17 Eli Lilly And Company Vinblastine in rheumatoid arthritis
US4259242A (en) * 1978-10-10 1981-03-31 Eli Lilly And Company Method of preparing vindesine sulfate
HU181940B (en) * 1979-11-02 1983-11-28 Richter Gedeon Vegyeszet Process for producing solutions of vincane derivatives for parentheral application
OA06421A (en) * 1980-06-10 1981-09-30 Omnium Chimique Sa Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.

Also Published As

Publication number Publication date
SE463804B (en) 1991-01-28
SE8304009L (en) 1984-01-20
IL69203A0 (en) 1983-11-30
AU1689183A (en) 1984-01-26
IE831646L (en) 1984-01-19
LU84910A1 (en) 1985-04-17
DE3324964A1 (en) 1984-01-19
IE55388B1 (en) 1990-08-29
CH654744A5 (en) 1986-03-14
IT8321644A0 (en) 1983-06-15
AU553514B2 (en) 1986-07-17
FR2531860B1 (en) 1986-09-26
PH19098A (en) 1986-01-02
GB2125292B (en) 1986-06-04
IT1170152B (en) 1987-06-03
GB8319146D0 (en) 1983-08-17
NL8302552A (en) 1984-02-16
NZ204868A (en) 1986-10-08
IL69203A (en) 1986-03-31
FR2531860A1 (en) 1984-02-24
GB2125292A (en) 1984-03-07
HK43087A (en) 1987-06-05
BE897280A (en) 1984-01-13
NL184146B (en) 1988-12-01
NL184146C (en) 1989-05-01
DE3324964C2 (en) 1991-03-14
HU191538B (en) 1987-03-30

Similar Documents

Publication Publication Date Title
FR2483926B1 (en)
NO865079L (en) PROCEDURE FOR THE PREPARATION OF STABILIZED HUMAN WEB PLASMINOGEN ACTIVATOR PREPARATIONS.
DE3880047D1 (en) COMPOSITION OF AN ADDITION.
ES521422A0 (en) PROCEDURE FOR THE OBTAINING OF N-GLYCOSYLATED CARBOXYLAMIDE DERIVATIVES.
GB2146527B (en) Use of benzothiophene derivatives as antiasthmatic agents
SE8304009L (en) PHARMACEUTICAL COMPOSITION
SE8303003L (en) AGENTS TO OKA ANTITUMOR EFFECTS OF ANTITUMOR AGENTS
SE7609055L (en) VETERINARY COMPOSITIONS
SE8704952L (en) PHARMACEUTICAL COMPOSITION
ES2028917T3 (en) A PROCEDURE FOR PREPARING A STABLE INJECTABLE PHARMACEUTICAL COMPOSITION.
IL57298A0 (en) Pharmaceutical compositions containing prostaglandin derivatives and their preparation
ES2052530T3 (en) LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF PHENYLQUINOLINE CARBOXYLIC ACIDS.
SE8503447D0 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS, INCLUDING DIHYDROXY-1,8-PHENYL-10-ANTRON-9 AS AN ACTIVE INGREDIENT, AS WELL AS THE PREPARATION OF THE ACTIVE SUBSTANCE
PT98190A (en) Process for the preparation of pharmaceutical compositions for stabilizing blood plasma during pasteurization
SE8400971D0 (en) PROPHYLACTIC AND PLAYING AGENTS FOR ARTERIOS SClerosis
FI873483A (en) OXIRANPSEUDOOLIGOSACKARIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DERAS ANVAENDNING OCH PHARMACEUTISKA PREPARAT.
SE8202962L (en) 2-METOXYPHENYL ESTERS OF N-SUBSTITUTED AMINO ACIDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
SE8004306L (en) ERGOPEPTIN DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
SE7902669L (en) ANTIBACTERIAL COMPOSITION
GB2021581A (en) Stabilisation of PGl2 derivatives
SE8302034L (en) DIBENS (CD, F) INDOLD DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE
IT8322402A0 (en) PROCEDURE FOR THE PREPARATION OF NON-SEDIMENTING AQUEOUS DISPERSIONS.
DK34882A (en) PROCEDURE FOR THE PREPARATION OF PEPTIDE DERIVATIVES
IT8819103A0 (en) PROCEDURE FOR THE PREPARATION OF CEFAMANDOL NAFATE AND ITS SALTS.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304009-7

Format of ref document f/p: F

NUG Patent has lapsed